Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-057604

President sold 33,618 shares at $70.00 ($2,353,260)

  • President acquired 33,618 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2019-11-19 Option exercise +33,618 $14.43 $485,108 33,618 D
Novak Rodger President 2019-11-19 Sale −33,618 $70.00 $2,353,260 0 D
Derivatives
Novak Rodger President 2019-11-19 Option exercise · Stock Option (Right to Buy) −33,618 236,382 D
Open-market sales · 33,618 sh · avg $70.00 · $2,353,260
Loading xslF345X03/doc4.xml…